Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI ‐SDS—A case series
ConclusionsThe observed decrease in BMI trajectories with MPH use for one year is clinically meaningful in this group of patients, since the natural course would have been associated with a pronounced increase in BMI, leading to comorbidities and complications over time.
Source: Pediatric Obesity - Category: Eating Disorders & Weight Management Authors: Stephanie Brandt,
Julia Schnurbein,
Belinda Lennerz,
Katja Kohlsdorf,
Heike Vollbach,
Christian Denzer,
Harald Bode,
Johannes Hebebrand,
Martin Wabitsch Tags: ORIGINAL RESEARCH Source Type: research
More News: Children | Concerta | Eating Disorders & Weight Management | Genetics | Hyperactivity | Methylphenidate | Obesity | Pediatrics | Ritalin | Sleep Disorders | Sleep Medicine | Tics